GeoVax Labs, Inc. (GOVX)

GeoVax Labs Statistics

Total Valuation

GeoVax Labs has a market cap or net worth of $26.25 million. The enterprise value is $24.83 million.

Market Cap	26.25M
Enterprise Value	24.83M

Important Dates

The next estimated earnings date is Wednesday, November 6, 2024, after market close.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	n/a

Share Statistics

GeoVax Labs has 8.39 million shares outstanding. The number of shares has increased by 25.27% in one year.

Shares Outstanding	8.39M
Shares Change (YoY)	+25.27%
Shares Change (QoQ)	+7.30%
Owned by Insiders (%)	0.53%
Owned by Institutions (%)	1.36%
Float	8.34M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	21.91
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	82.58
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.60

Current Ratio	0.60
Quick Ratio	0.29
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3,735.44

Financial Efficiency

Return on equity (ROE) is -362.39% and return on invested capital (ROIC) is -227.04%.

Return on Equity (ROE)	-362.39%
Return on Assets (ROA)	-134.34%
Return on Capital (ROIC)	-227.04%
Revenue Per Employee	$17,687
Profits Per Employee	-$1.58M
Employee Count	17
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -62.25% in the last 52 weeks. The beta is 3.08, so GeoVax Labs's price volatility has been higher than the market average.

Beta (5Y)	3.08
52-Week Price Change	-62.25%
50-Day Moving Average	3.53
200-Day Moving Average	3.09
Relative Strength Index (RSI)	42.06
Average Volume (20 Days)	12,721,141

Short Selling Information

The latest short interest is 261,925, so 3.12% of the outstanding shares have been sold short.

Short Interest	261,925
Short Previous Month	623,333
Short % of Shares Out	3.12%
Short % of Float	3.14%
Short Ratio (days to cover)	0.33

Income Statement

In the last 12 months, GeoVax Labs had revenue of $300,677 and -$26.92 million in losses. Loss per share was -$12.79.

Revenue	300,677
Gross Profit	-21.58M
Operating Income	-27.24M
Pretax Income	-26.92M
Net Income	-26.92M
EBITDA	-27.16M
EBIT	-27.24M
Loss Per Share	-$12.79

Balance Sheet

The company has $1.56 million in cash and $142,292 in debt, giving a net cash position of $1.42 million or $0.17 per share.

Cash & Cash Equivalents	1.56M
Total Debt	142,292
Net Cash	1.42M
Net Cash Per Share	$0.17
Equity (Book Value)	-2.31M
Book Value Per Share	-0.55
Working Capital	-2.56M

Cash Flow

In the last 12 months, operating cash flow was -$23.00 million and capital expenditures -$25,141, giving a free cash flow of -$23.02 million.

Operating Cash Flow	-23.00M
Capital Expenditures	-25,141
Free Cash Flow	-23.02M
FCF Per Share	-$2.75

Margins

Gross Margin	n/a
Operating Margin	-9,059.16%
Pretax Margin	-8,951.60%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GeoVax Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.27%
Shareholder Yield	-25.27%
Earnings Yield	-102.53%
FCF Yield	-87.71%

Analyst Forecast

The average price target for GeoVax Labs is $14.00, which is 347.28% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.00
Price Target Difference	347.28%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on January 31, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Jan 31, 2024
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

GeoVax Labs has an Altman Z-Score of -61.16 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-61.16
Piotroski F-Score	1